hero media helmsley

Our Grants

GRANT DATE AMOUNT PROGRAM
Stichting Health Action International
Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS) Study Phase IV
11.20.2023 $3,499,991.00 Type 1 Diabetes, Improve Outcomes
Jaeb Center For Health Research Foundation, Inc.
Pregnancy Data Repository to Assess Management of Type 1 Diabetes with Diabetes Technology (PRAM-T1D)
11.20.2023 $3,928,454.00 Type 1 Diabetes, Improve Outcomes
Jaeb Center For Health Research Foundation, Inc.
Leveraging new ultra-rapid insulins with AID for exercise management with T1D
11.20.2023 $1,217,662.00 Type 1 Diabetes, Improve Outcomes
The City of Hope
CD318 mediated regulation of islet autoantigen specific T cell immunity
11.08.2023 $905,300.00 Type 1 Diabetes, Prevent & Delay
The Regents of the University of Colorado, Denver
Impact of menstruation on glycemic response and exercise
10.19.2023 $2,462,329.00 Type 1 Diabetes, Improve Outcomes
Jaeb Center For Health Research Foundation, Inc.
Educational intervention to support Diabetes Guidance for Exercise (EDGE)
10.19.2023 $1,425,628.00 Type 1 Diabetes, Improve Outcomes
Université Catholique de Louvain
Search for mechanisms responsible for the impaired glucagon secretion in T1D and for strategies to correct them
10.19.2023 $907,500.00 Type 1 Diabetes, Prevent & Delay
Board of Trustees of the Leland Stanford Junior University
Development of Personalized Decision Support tool using NetIOB to help manage exercise for people with T1D
10.19.2023 $2,206,910.00 Type 1 Diabetes, Improve Outcomes
The Regents of the University of California, Santa Barbara
Exercise specific AID algorithm for Type 1 Diabetes
10.04.2023 $2,977,229.00 Type 1 Diabetes, Improve Outcomes
The Regents of the University of California, San Francisco
Identification and analysis of extreme forms of type 1 diabetes, establishment of a data commons
10.04.2023 $1,299,998.00 Type 1 Diabetes, Prevent & Delay
JDRF International
Joining Forces: Building a Shared 'Grand Access Strategy' For Saving T1D Lives
09.19.2023 $1,000,000.00 Type 1 Diabetes, Improve Outcomes
Université de Genève
Preclinical testing of S100A9 to improve glycemic control in type 1 diabetes
09.19.2023 $2,485,485.00 Type 1 Diabetes, Prevent & Delay
Regents of the University of Minnesota
Engineering antigen-specific regulatory T cells for use in type 1 diabetes (Phase 3)
09.19.2023 $1,508,250.00 Type 1 Diabetes, Prevent & Delay
Regents of the University of Minnesota
Therapeutic use of peptide:MHC mAbs for T1D
09.19.2023 $660,000.00 Type 1 Diabetes, Prevent & Delay
International Alliance for Diabetes Action Inc
Seed funding support
09.06.2023 $2,579,400.00 Type 1 Diabetes, Improve Outcomes
Benaroya Research Institute at Virginia Mason
TruCulture sample analysis for TN22 HCQ
08.09.2023 $297,957.00 Type 1 Diabetes, Prevent & Delay
Vayu Health
Vayu Health Phase 2 - Scale and Spread of Value Based Payment Ecosystem for Medicaid Beneficiaries Living with Type 1 and Type 2 Diabetes
08.09.2023 $14,445,966.00 Type 1 Diabetes, Improve Outcomes
University of Florida
Generating autoantigen-specific antibody-producing hybridomas as a renewable source of islet autoantibodies
08.09.2023 $118,137.00 Type 1 Diabetes, Prevent & Delay
University of Exeter
B cell signatures in Type 1 Diabetes
08.09.2023 $800,596.00 Type 1 Diabetes, Prevent & Delay
The Regents of the University of Colorado, Denver
T and B cell Receptor Atlas Across Tissues and Stages of Type 1 Diabetes
07.24.2023 $1,503,000.00 Type 1 Diabetes, Prevent & Delay
You can filter rows:
1 - 20 of 858 <   > Last